Pharmacokinetics of LCQ908 in Patients With Renal Impairment

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

This study will compare the pharmacokinetics of LCQ908 in subjects with varying degrees of renal impairment to healthy subjects

Phase 1

Novartis Pharmaceuticals